Showing results (771-780 of 870) with videos related to
Sort By:
Pageof 87
BMJ Neurology Open|July 30, 2025
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registryAi-Lan Nguyen, Dana Horakova, Eva H Havrdova, et al.Plos One|January 18, 2013
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophyElena Stacy Mazzone, Marika Pane, Maria Pia Sormani, et al.Neurology|November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter studyAlice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.Nature Medicine|January 9, 2023
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 studyAngela Genchi, Elena Brambilla, Francesca Sangalli, et al.Neurology|December 21, 2022
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisGiacomo Boffa, Alessio Signori, Luca Massacesi, et al.Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.Journal of Neurology|November 27, 2022
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosisPaolo Preziosa, Maria A Rocca, Elisabetta Pagani, et al.Ebiomedicine|November 12, 2022
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trialJeffrey L Bennett, Orhan Aktas, William A Rees, et al.Multiple Sclerosis and Related Disorders|November 13, 2024
Utility of icobrain for brain volumetry in multiple sclerosis clinical practiceAi-Lan Nguyen, Maria Pia Sormani, Dana Horakova, et al.Multiple Sclerosis and Related Disorders|February 15, 2022
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorderRomain Marignier, Sean J Pittock, Friedemann Paul, et al.Pageof 87